Updated Jul 16, 2026 · Last SEC filing 2026-06-15
FATE THERAPEUTICS INC (FATE) has filed 16 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-15. 3 Form 8-K material event filings were reported by FATE in the last 90 days. 2 Form 144 notices of proposed sale were filed for FATE stock. InsiderAlpha tracks every FATE SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.
| SEC CIK | 0001434316 |
|---|
| Form 4 filings (90d) | 16 |
|---|---|
| Form 8-K filings (90d) | 3 |
| Form 144 notices (90d) | 2 |
| Latest Form 4 filing | 2026-06-15 |
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Valamehr Bahram | President and CEO | S — Open-market sale | 28.9K | $1.88 | $54K | SEC | |
| TAHL CINDY | See Remarks | S — Open-market sale | 25.6K | $1.88 | $48K | SEC | |
| TAHL CINDY | See Remarks | M — Option exercise | 44.4K | $1.05 | $47K | SEC | |
| TAHL CINDY | See Remarks | M — Option exercise | 122.2K | $1.32 | $161K | SEC | |
| EPSTEIN ROBERT S | Insider | M — Option exercise | 25.0K | $1.69 | $42K | SEC | |
| RASTETTER WILLIAM H | Insider | M — Option exercise | 25.0K | $1.69 | $42K | SEC | |
| Redmile Group, LLC | Director | J — Other acquisition / disposition | 8.98M | $0.00 | — | SEC | |
| Redmile Group, LLC | Director | J — Other acquisition / disposition | 8.98M | $0.00 | — | SEC | |
| TAHL CINDY | See Remarks | A — Grant or award | 100.0K | $0.00 | — | SEC | |
| Adawi Kamal | Chief Financial Officer | A — Grant or award | 25.0K | $0.00 | — | SEC | |
| Valamehr Bahram | President and CEO | A — Grant or award | 335.0K | $0.00 | — | SEC | |
| Valamehr Bahram | President and CEO | S — Open-market sale | 5.2K | $1.07 | $6K | SEC | |
| TAHL CINDY | See Remarks | S — Open-market sale | 10.6K | $1.06 | $11K | SEC | |
| Adawi Kamal | Chief Financial Officer | A — Grant or award | 75.0K | $0.00 | — | SEC | |
| Valamehr Bahram | President and CEO | S — Open-market sale | 14.5K | $1.06 | $15K | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for FATE THERAPEUTICS INC (FATE). Updated in real time as new filings are submitted to the SEC.
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Redmile Group, LLC | 11 | — |
| TAHL CINDY | 5 | $256K |
| EPSTEIN ROBERT S | 3 | $42K |
| RASTETTER WILLIAM H | 3 | $42K |
| Valamehr Bahram | 1 | $54K |
Form 144 must be filed before insiders sell restricted or control stock above SEC thresholds. A cluster of Form 144 notices often precedes a wave of insider distribution.
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in FATE insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
Open the live FATE dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.